https://www.live-feeds.com/feed/rfk-jr-s-hhs-is-allowing-these-6-unapproved-peptides-to-be-soldContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/rfk-jr-s-hhs-is-allowing-these-6-unapproved-peptides-to-be-soldhttps://www.live-feeds.com/feed/rfk-jr-s-hhs-is-allowing-these-6-unapproved-peptides-to-be-sold#u196895Thu, 12 Nov 2026 11:07:19 +0000The Department of Health and Human Services has introduced an interim enforcement discretion policy permitting compounding pharmacies to sell six unapproved peptides. Companies including Amble Health and Elysium Health have already launched or expanded access to these products through online medical care and research programs. While commercial enthusiasm for the wellness offerings grows, medical experts and oncologists in Western Pennsylvania and elsewhere warn of unknown risks, noting that the substances have not been proven safe and effective and that clinical evidence lags behind market ava